We designed a novel nanoplatform, Pt@BSA-RM, that is capable of sensitizing breast cancer cells to radiotherapy.
Zhang et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: